Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $124,084 - $143,583
-771 Reduced 9.16%
7,643 $1.32 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $1.21 Million - $1.46 Million
-8,314 Reduced 49.7%
8,414 $1.4 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $3.61 Million - $4.34 Million
-27,558 Reduced 62.23%
16,728 $2.45 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $472,451 - $581,604
3,186 Added 7.75%
44,286 $6.57 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $6.41 Million - $8.22 Million
41,100 New
41,100 $7.07 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $2.75 Million - $3.32 Million
-17,668 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $716,688 - $843,054
4,977 Added 39.22%
17,668 $2.78 Million
Q4 2020

Feb 16, 2021

SELL
$157.07 - $174.35 $5.38 Million - $5.97 Million
-34,269 Reduced 72.97%
12,691 $2.1 Million
Q3 2020

Nov 16, 2020

SELL
$137.1 - $165.37 $3.6 Million - $4.34 Million
-26,240 Reduced 35.85%
46,960 $7.77 Million
Q2 2020

Aug 14, 2020

SELL
$111.92 - $142.53 $226,302 - $288,195
-2,022 Reduced 2.69%
73,200 $10 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $3.25 Million - $5.08 Million
35,025 Added 87.13%
75,222 $8.85 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $2.42 Million - $2.77 Million
-20,802 Reduced 34.1%
40,197 $5.32 Million
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $6.87 Million - $7.83 Million
60,999 New
60,999 $7.6 Million
Q4 2017

Feb 14, 2018

SELL
$63.24 - $72.8 $2.5 Million - $2.88 Million
-39,500 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$59.73 - $65.4 $2.36 Million - $2.58 Million
39,500
39,500 $2.52 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $84.9B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.